Corentec Co., Ltd. announced that it expects to receive KRW 20 billion in funding from Premier Partners, LLC, Corstone Asia Co., Ltd.
November 07, 2016
Share
Corentec Co., Ltd. (KOSDAQ:A104540) announced a private placement of 7th registered unsecured unguaranteed private convertible bonds for gross proceeds of KRW 20,000,000,000 on November 8, 2016. The bonds will not bear any interest and will have a yield to maturity of 0%. The bonds will mature on November 23, 2021. The bonds will be convertible into common shares at a fixed conversion price of KRW 16,000 per share between November 24, 2017 and November 23, 2021. The transaction has been approved by the board of the company. The payment date is November 23, 2016.
Corentec Co., Ltd. is a Korea-based company engaged in the development, manufacture and sale of orthopedic implants. The Companyâs products consist of hip products, including primary systems, hemi-arthroplasty systems and revision systems, such as cementless femoral stems, cemented femoral stems, cups for acetabular systems, bearing systems and others; knee products, including primary knee system fixed type, primary knee system mobile type, revision knee systems and augments systems, and spine products, including pedicle screws and peek cages. The Company mainly provides its hip products under the brand name of BENCOX, knee products under the brand name of LOSPA and spine products under the brand name of LOSPA IS. The Company distributes its products within domestic market and to overseas markets.
CORENTEC CO., LTD. 
